SecBot SecBot

IXHL

Incannex Healthcare Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001873875 Biotech & Drug Discovery
$2.63 +0.02 (+0.77%)
Oct 27 4:00 PM ET · prev $2.61
Market cap
$32.6M
Nano cap
Median target
🔒 Subscribers only
Next earnings
Nov 12
in 16 days · EPS est. −$0.52
1 year
−75.0%
from $10.50 · Oct 27
30 days
−16.5%
from $3.15
52-week range
$2.56–14.37
−82% from high · low Apr 6
Avg volume 20D
57.1K
Oct 12 spike 148.6K
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read BULLISH 3 reports · 90 days
Balance 0 bearish · 2 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Nov 12, 2026
Strongest NEUTRAL Incannex Healthcare provided a corporate update covering clinical progress, intellectual property, and a…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 2 added (0 new), 1 trimmed or exited.

  • EstimatesFLAT

    Current-quarter EPS estimate −$0.510 → −$0.518 over 90 days. 0 up, 1 down in 30 days.

  • TrendDOWNTREND

    19% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
LPL Financial LLCDOUBLED148,178$557.1K
UBS Group AGNEAR_EXIT3,610$13.6K
MORGAN STANLEYADD3,558$13.4K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jun 2026

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Jun 8, 2026Alliance Global Partners
INITIATE
INITIATEBuy

Earnings setup

Estimates
Nov 12
reports in 16 days
−$0.52
EPS estimate, this quarter
−2%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.52-$0.52–-$0.52-1.6%$0.00
Next Q-$0.53-$0.53–-$0.53+10.6%$0.00
Current FY-$2.23-$2.23–-$2.23+7.4%$0.00
Next FY-$2.44-$2.44–-$2.44+6.7%$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
IXHL Q1 2027 Earnings Scheduled — 2026-11-12
Recent
Sep 28, 2026
Earnings date
IXHL Q4 2026 Earnings Scheduled — 2026-09-28
Sep 25, 2026
Earnings result
IXHL Q4 2026 Earnings: EPS $-4.934 (-547.5% vs est)
Jul 27, 2026
Clinical Trial
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA
Phase 3 · COMPLETED
Jul 23, 2026
FDA
Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea
MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a…
Jul 15, 2026
Short interest
Short Interest: IXHL up 97% to 1.0M shares
Settlement 2026-07-15 | Days to cover: 3.65 | ≈8.40% of shares outstanding (est.)

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 28, 2026 Earnings calendar
IXHL Q4 2026 Earnings Scheduled — 2026-09-28
Sep 9, 2026 SEC
Incannex Healthcare provided a corporate update covering clinical progress, intellectual property, and a strong cash…
8-K — Impact 4/10
Aug 25, 2026 SEC
Incannex Healthcare announced the first patient dosed in the DReAMzz Phase 2 dose-optimization study of IHL-42X for…
8-K — Impact 5/10
Aug 11, 2026 SEC
Incannex Healthcare announced receipt of the final A$5.1 million (~$3.4M USD) R&D tax incentive refund from the…
8-K — Impact 5/10
Jul 23, 2026 Press
Incannex Healthcare announced that participant screening has commenced in its DReAMzz Phase 2 dose confirmation study…
Impact 6/10
Jun 30, 2026 Inst.
LPL Financial LLC — DOUBLED
148,178 shares ($557.1K)
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
3,610 shares ($13.6K)
Jun 23, 2026 Event
Dickson v. Vitas Healthcare Corporation of Illinois
Court ruling from District Court, N.D. Illinois. Docket: 1:26-cv-03741

SecBot reports

13 filings · 5 press releases · 5 bullish · 0 bearish · 1 mixed · 7 neutral
All IXHL filing & press-release reports (18)